10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymehr
08.12.2023 – 11:13Helmholtz Zentrum MünchenNew Source of Stem Cells in Injury-Affected Brains of Patientsmehr
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsEin Dokumentmehr
09.08.2023 – 16:52Helmholtz Zentrum MünchenA New Ally in Fighting Brain Diseases: Our Very Own Skullmehr
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemehr
28.06.2023 – 17:13Helmholtz Zentrum MünchenNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmehr
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmehr
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmehr
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmehr
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmehr
25.05.2022 – 15:00Sysmex Europe SE3Sysmex Europe SE and Sysmex Inostics GmbH launch two CE-IVD certified Plasma-SeqSensei™ liquid biopsy kits: Solid Cancer IVD Kit and Breast Cancer IVD KitVisit our website!Ein Dokumentmehr
01.02.2022 – 11:05Ottobock SE & Co. KGaAPress Information: Ottobock strengthens its NeuroMobility business areamehr
29.11.2021 – 11:44Einhell Germany AG4RTL Donation Marathon: Einhell offers support to children suffering from cancerEin Dokumentmehr
20.10.2021 – 16:30Sysmex Inostics GmbHNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inosticsmehr
24.06.2021 – 17:28Helmholtz Zentrum MünchenGastrulation research reveals novel details about embryonic developmentmehr
27.05.2021 – 10:35BrainRepair UGInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15Mmehr
10.05.2021 – 14:13Ottobock SE & Co. KGaA3High-tech prosthesis for enhanced safety: New Kenevo knee joint availableVideo on the new Kenevo mehr
13.04.2021 – 14:04Fördergesellschaft IZB mbH2Lindis Biotech develops immunotherapy against bladder cancerIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
03.02.2021 – 13:30Fördergesellschaft IZB mbH3World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic toolsIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
15.01.2021 – 15:15Semdor Pharma GroupMerger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabismehr
30.09.2020 – 13:00BrainRepair UGRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Planmehr
04.06.2020 – 14:16SYNformulas GmbH2Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipationmehr
27.04.2020 – 17:22Helmholtz Zentrum München2Beta cells from stem cells: Potential for cell replacement therapyRead the studymehr
06.11.2019 – 09:30Hitachi Medical Systems Europe Holding AG2Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AImehr
25.10.2019 – 10:03Helmholtz Zentrum MünchenHelmholtz Zentrum München allies with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetesLearn more about Helmholtz Zentrum Münchenmehr
17.10.2019 – 17:34Fördergesellschaft IZB mbHThe development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZBIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr